 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes |
| Hyun Goo Kang, Eun Young Choi, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sung Chul Lee, Min Kim |
|
Korean J Ophthalmol. 2018;32(6):451-458. Published online November 27, 2018 DOI: https://doi.org/10.3341/kjo.2018.0011 |
|
Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes Korean Journal of Ophthalmology. 2018;32(6):451  Treatment for non-type 1 retinopathy of prematurity by intravitreal injection of anti-vascular endothelial growth factor drugs . 2022; ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PADA RETINOPATHY OF PREMATURITY Human Care Journal. 2021;6(2):358 Treatment for non-type 1 retinopathy of prematurity by intravitreal injection of anti-vascular endothelial growth factor drugs . 2022; Exploring the Limits: The Challenge of Finding the Right Dose for Anti–Vascular Endothelial Growth Factor Treatment in Retinopathy of Prematurity Ophthalmology. 2018;125(12):1967-1968 Erratum to Retinopathy of Prematurity: Evolving Treatment with anti-Vascular Endothelial Growth Factor. Am J Ophthalmol 2020;218:208-213. American Journal of Ophthalmology. 2021;231:213 How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example Ophthalmology. 2018;125(10):1485-1487 Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come Neonatology. 2014;106(3):254-260 Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries Pediatric Health, Medicine and Therapeutics. 2023;Volume 14:59-69 Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors Early Human Development. 2012;88(12):937-941 |
